期刊
MOLECULAR AND CELLULAR BIOCHEMISTRY
卷 317, 期 1-2, 页码 189-196出版社
SPRINGER
DOI: 10.1007/s11010-008-9848-8
关键词
peroxisome proliferator-activated receptor gamma; calcineurin; nuclear factor of activated T-cell; endothelin-1; cardiac hypertrophy
类别
资金
- National Natural Science Foundation of China [30672459, 30772576]
- Key Natural Science Foundation of Guangdong Province, People's Republic of China [7117380]
- People's Government of Guangdong Province, People's Republic of China [2003A 30904]
Peroxisome proliferator-activated receptor gamma (PPAR-gamma) has been described as a negative regulator of cardiac hypertrophy. A better understanding of PPAR-gamma and cardiac hypertrophy may facilitate the development of novel therapeutic strategies to treat heart diseases related to cardiac hypertrophy by mimicking the naturally preferred mechanisms. In the present study, we investigated the interaction between PPAR-gamma and calcineurin/nuclear factor of activated T-cells (NFAT) in endothelin-1 (ET-1)-induced hypertrophy of neonatal rat cardiac myocytes. The results suggest that the treatment of cultured cardiac myocytes with a PPAR-gamma ligand, rosiglitazone, inhibited the ET-1-induced increase in protein synthesis, surface area, calcineurin enzymatic activity, and protein expression. Both the application of rosiglitazone and overexpression of the PPAR-gamma inhibited the nuclear translocation of NFATc4. Moreover, co-immunoprecipitation studies showed that rosiglitazone enhanced the association between PPAR-gamma and calcineurin/NFAT. These results suggest that ET-1-induced cardiac hypertrophy is inhibited by activation of PPAR-gamma, which is at least partly due to cross-talk between PPAR-gamma and calcineurin/NFAT.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据